Table 2.

Compliance analysis between handwritten and electronic groups.

Compliance items		Handwritten (N=130), n (%)	Electronic (N=130), n (%)	P value
Prescriber		70 (53.8)	117 (90)	.03
	Last name	124 (95.4)	130 (100)	.01
	First name	121 (93.1)	130 (100)	<.01
	Specialty or unit	120 (92.3)	117 (90)	.51
	Registration number	70 (53.8)	130 (100)	<.001
	Signature	127 (97.7)	130 (100)	.08
Center		130 (100)	130 (100)	—a
	Name	130 (100)	130 (100)	—
	Address	130 (100)	130 (100)	—
	Registration number	130 (100)	130 (100)	—
Prescription		65 (50)	112 (86.2)	<.001
	Contact	68 (52.3)	112 (86.2)	<.001
	Date	127 (97.7)	130 (100)	.08
	Readability	127 (97.7)	130 (100)	.08
	Prescription excluding contactb	124 (95.4)	130 (100)	.03
Patient		0 (0)	130 (100)	<.001
	Patient excluding social numberc	36 (27.7)	130 (100)	<.001
	Patient excluding social number and birthdated	105 (80.8)	130 (100)	<.001
	Last name	129 (99.2)	130 (100)	.32
	First name	105 (80.8)	130 (100)	<.001
	Birth date	36 (27.7)	130 (100)	<.001
	Social number	0 (0)	130 (100)	<.001
Molecule (international name only)		6 (4.6)	82 (63.1)	<.001
	Molecule (international or brand name)e	39 (30)	105 (80.8)	<.001
	International name	16 (12.3)	90 (69.2)	<.001
	Brand name	116 (89.2)	95 (73.1)	<.001
	Drug type	63 (48.5)	117 (90)	<.001
	Dosage unit	77 (59.2)	116 (89.2)	<.001
	Dosage	114 (87.7)	127 (97.7)	.002
	Duration	107 (82.3)	126 (96.9)	<.001

^aNot applicable.

^bAnalysis was performed without considering the presence or absence of contact.

^cAnalysis was performed without considering the presence or absence of social number.

^dAnalysis was performed without considering the presence or absence of social number nor birthdate.

^eAnalysis was performed without considering the presence or absence of international name, brand name was allowed indifferently.